Showing results (151-160 of 222) with videos related to
Sort By:
Pageof 23
Heart (British Cardiac Society)|February 23, 2011
Cardiac resynchronisation therapy in patients with heart failure and a normal QRS duration: the RESPOND studyPaul W X Foley, Kiran Patel, Nick Irwin, et al.Arthritis and Rheumatism|July 1, 1996
Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysisF C Arnett, J D Reveille, R Goldstein, et al.Genomics|January 1, 1992
Assignment of tyrosine-specific T-cell phosphatase to conserved syntenic groups on human chromosome 18 and mouse chromosome 18A Y Sakaguchi, V L Sylvia, L Martinez, et al.Human Heredity|March 1, 1997
No evidence of linkage for cleft lip with or without cleft palate to a marker near the transforming growth factor alpha locus in two populationsD F Wyszynski, N Maestri, A F Lewanda, et al.Journal of Pediatric Urology|April 23, 2024
Long-term bladder outcomes using a prescriber pattern scoring system for posterior urethral valvesN M Haney, T Sholklapper, C Crigger, et al.Human Genetics|January 1, 1997
Evidence for an association between markers on chromosome 19q and non-syndromic cleft lip with or without cleft palate in two groups of multiplex familiesD F Wyszynski, N Maestri, I McIntosh, et al.American Journal of Medical Genetics|January 24, 1998
Application of transmission disequilibrium tests to nonsyndromic oral clefts: including candidate genes and environmental exposures in the modelsN E Maestri, T H Beaty, J Hetmanski, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 16, 2007
Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathyShajil Chalil, Paul W X Foley, Sarkaw A Muyhaldeen, et al.Heart (British Cardiac Society)|July 14, 2009
Development and validation of a clinical index to predict survival after cardiac resynchronisation therapyF Leyva, P W X Foley, B Stegemann, et al.Nature Genetics|July 1, 1995
A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasiaG A Bellus, I McIntosh, E A Smith, et al.Pageof 23